Acetic Acid

Acetic Acid

SCHEMBL4630370

CC(=O)O.COc1cccc(Oc2ccc(N)cc2)c1

nearest known ligand 0.81

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.81
ALDH1A1 P00352 3/20 0.65
MEN1 O00255 3/20 0.65
KMT2A Q03164 3/20 0.65
MITF O75030 1/20 0.65
GAA P10253 1/20 0.65
MAPT P10636 1/20 0.65
GFER P55789 1/20 0.65
NLRP1 Q9C000 1/20 0.65
NOD2 Q9HC29 1/20 0.65
MTNR1B P49286 10/20 0.61
MTNR1A P48039 6/20 0.61
PGR P06401 1/20 0.56
KDM4E B2RXH2 2/20 0.55
POLB P06746 1/20 0.55
MAOA P21397 1/20 0.53
NPC1 O15118 1/20 0.53
RAB9A P51151 1/20 0.53
NLRP3 Q96P20 1/20 0.53
ACACB O00763 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL555032 0.90 SMN1; SMN2 (1.00) SMN1; SMN2ALDH1A1MEN1KMT2AMITF
SCHEMBL1980004 0.90 SMN1; SMN2 (1.00) SMN1; SMN2ALDH1A1MEN1KMT2AMITF
Acetic Acid SCHEMBL31248068 0.88 MTNR1B (0.65) SMN1; SMN2MTNR1BMTNR1APGRKDM4E
Acetic Acid SCHEMBL4630472 0.84 ALDH1A1 (0.61) SMN1; SMN2ALDH1A1MEN1KMT2AMITF
Acetic Acid SCHEMBL4630367 0.84 PARP10 (0.68) SMN1; SMN2ALDH1A1KMT2AMTNR1BMTNR1A
4-Phenoxyaniline SCHEMBL4630332 0.84 MAOA (0.75) SMN1; SMN2ALDH1A1MEN1KMT2AMITF
Acetic Acid SCHEMBL4630421 0.82 SMN1; SMN2 (0.57) SMN1; SMN2ALDH1A1MEN1KMT2AMITF
Acetic Acid SCHEMBL4630447 0.81 CYP3A4 (0.77) SMN1; SMN2ALDH1A1KDM4EPOLBNPC1
Acetic Acid SCHEMBL28904976 0.80 TDP1 (0.73) SMN1; SMN2ALDH1A1MAPTKDM4ENPC1
SCHEMBL554191 0.80 ALDH1A1 (0.91) SMN1; SMN2ALDH1A1MEN1KMT2AMITF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1919875-A2 PYRAZOLE DERIVATIVES AND THEIR USE AS PKA AND PKB MODULATORS Astex Therapeutics Limited (GB) 2008-05-14 EP claimed
WO-2006136829-A2 PYRAZOLE DERIVATIVES AND THEIR USE AS PKA AND PKB MODULATORS ASTEX THERAPEUTICS LIMITED (GB) 2006-12-28 WO claimed
EP-1919875-A2 PYRAZOLE DERIVATIVES AND THEIR USE AS PKA AND PKB MODULATORS Astex Therapeutics Limited (GB) 2008-05-14 EP disclosed
WO-2006136829-A2 PYRAZOLE DERIVATIVES AND THEIR USE AS PKA AND PKB MODULATORS ASTEX THERAPEUTICS LIMITED (GB) 2006-12-28 WO disclosed